Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

DPP-4 inhibitors improve your blood sugar without making it drop too low alogliptin (Nesina), linagliptin (Tradjenta), saxagliptin (Onglyza), and sitagliptin (Januvia) glucagon-like peptides ...

Amphastar's intranasal glucagon dry powder, Baqsimi, and Novo Nordisk’s dasiglucagon auto-injector, Zegalogue, compete with Gvoke. McCulloch said he had yet to see the rivals make a big ...

Glucagon is a recognised therapy for the ... 2019 as a hypoglycaemia rescue therapy for diabetics. Eli Lilly's nasal spray Baqsimi was also approved in 2019 for a similar indication.

Nasal sprays can treat congestion and other symptoms of seasonal allergies or a cold. They work by delivering a fine mist of medication into your nostrils. Since the lining of your nose is rich with ...

The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

After hours: January 24 at 4:20:02 PM EST Loading Chart for AMPH ...

Most of this rise was associated with the expansion of the sales force for recently purchased BAQSIMI. Revenues rose nearly six percent on a year-over-year basis to $191.2 million, some $3 million ...

When the sinuses and nasal passages become inflamed, it’s known as sinusitis. Inflammation can occur because of conditions such as structural issues in the nose or a sinus infection. The terms ...

Getting access to Medicare after years of paying into the system can feel like finally “making it.” However, once you begin receiving Medicare benefits, it’s important to understand that ...